Cellaria Cancer Cell Models and Media
AMSBIO now provides Cellaria patient-derived, ex-vivo cancer cell models and cell culture media.
Over the past 20 years, cancer research has shed new light on the diversity, individuality, and complexity of the disease.
This discovery has accelerated the need for a new type of cancer model, one that allows researchers to gain more actionable insights and develop therapeutics that more closely align with the unique needs of patients.
Cellaria has answered the call by developing breakthrough cell models and media that empower scientists to conduct research more accurately, efficiently, and intelligently.
Cellaria's Cell Models
Cellaria's ex-vivo models are derived directly from patient tumors to reflect the unique nature and complexity of each patient.
- Developed with a breakthrough process
Our process eliminates large scale cellular adaptation and minimizes genetic drift in culture.
- Unparalleled stability
Our cell models are stable and show high concordance to the original tumor genotype through high passage as measured by SNP analysis.
- Backed by extensive data
Our models are traceable back to initial patient tumor and clinical conditions, simplifying the analysis of patient-specific responses.
- Stringent quality controls
Our intensive screening process provides lot-to-lot reproducibility and our cell models are screened for all major categories of contaminants.
- Predictable growth rates
Obtain the cells you need for high-throughput drug screening via optimized expansion protocols.
Cellaria Cell Culture Media
Cellaria provides innovative media for your primary culture needs.
Our WIT and Renaissance products enable high rates of success in culturing your patient samples past 15 population doublings.
Renaissance Media (RETM) Cancer Cell Media
Achieve 6X more success deriving human cancer cell lines than traditional methods.
- Cultivate tumors with greater success:
Over 80% success establishing extended primary cultures from patient tumor samples.
- Simple feeder-free protocol:
No feeder cells or genetic manipulation of the cells is required.
- Unsurpassed growth:
Promotes the expansion of primary cancer cells for greater than 15 population doublings, without a cell-selection phase typically seen with traditional media.
- Genomic stability to late passage:
Cells derived and expanded in Renaissance exhibit high genomic concordance to the original tumor.
Our WIT Media is designed to optimize the expansion of normal human mammary epithelial cells and human fallopian tissue.
Completely defined and serum-free, WIT media supports expansion over 15 population doublings—without the growth arrest seen in
other normal primary culture media. WIT has been used for a broad range of applications by scientists including growth of lymphoma and prostate luminal cells.